Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

PTEN loss mediates clinical cross-resistance to CDK4/6 and PI3Kα inhibitors in breast cancer.

Costa C, Wang Y, Ly A, Hosono Y, Ellen M, Walmsley CS, Huynh T, Healy C, Peterson R, Yanase S, Jakubik CT, Henderson LE, Damon LJ, Timonina D, Sanidas I, Pinto CJ, Mino-Kenudson M, Stone JR, Dyson NJ, Ellisen LW, Bardia A, Ebi H, Benes CH, Engelman JA, Juric D.

Cancer Discov. 2019 Oct 8. pii: CD-18-0830. doi: 10.1158/2159-8290.CD-18-0830. [Epub ahead of print]

PMID:
31594766
2.

Distinct parafacial regions in control of breathing in adult rats.

Huckstepp RTR, Cardoza KP, Henderson LE, Feldman JL.

PLoS One. 2018 Aug 10;13(8):e0201485. doi: 10.1371/journal.pone.0201485. eCollection 2018.

3.

Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer's Disease.

Henderson LE, Abdelmegeed MA, Yoo SH, Rhee SG, Zhu X, Smith MA, Nguyen RQ, Perry G, Song BJ.

Open Neurol J. 2017 Nov 16;11:48-58. doi: 10.2174/1874205X01711010048. eCollection 2017.

4.

Interactions between respiratory oscillators in adult rats.

Huckstepp RT, Henderson LE, Cardoza KP, Feldman JL.

Elife. 2016 Jun 14;5. pii: e14203. doi: 10.7554/eLife.14203.

5.

Role of parafacial nuclei in control of breathing in adult rats.

Huckstepp RT, Cardoza KP, Henderson LE, Feldman JL.

J Neurosci. 2015 Jan 21;35(3):1052-67. doi: 10.1523/JNEUROSCI.2953-14.2015.

6.

Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease.

Song BJ, Abdelmegeed MA, Henderson LE, Yoo SH, Wan J, Purohit V, Hardwick JP, Moon KH.

Oxid Med Cell Longev. 2013;2013:781050. doi: 10.1155/2013/781050. Epub 2013 Apr 3. Review.

7.

Resource seeking strategies of zoosporic true fungi in heterogeneous soil habitats at the microscale level.

Gleason FH, Crawford JW, Neuhauser S, Henderson LE, Lilje O.

Soil Biol Biochem. 2012 Feb;45(2):79-88.

8.

PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.

Abdelmegeed MA, Yoo SH, Henderson LE, Gonzalez FJ, Woodcroft KJ, Song BJ.

J Nutr. 2011 Apr 1;141(4):603-10. doi: 10.3945/jn.110.135210. Epub 2011 Feb 23.

9.

Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress.

Yoo SH, Park O, Henderson LE, Abdelmegeed MA, Moon KH, Song BJ.

Toxicol Lett. 2011 Apr 10;202(1):23-9. doi: 10.1016/j.toxlet.2011.01.013. Epub 2011 Jan 22.

10.

Clinical research in low-literacy populations: using teach-back to assess comprehension of informed consent and privacy information.

Kripalani S, Bengtzen R, Henderson LE, Jacobson TA.

IRB. 2008 Mar-Apr;30(2):13-9. No abstract available.

PMID:
18512655
11.

Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions.

Kripalani S, Henderson LE, Jacobson TA, Vaccarino V.

Mayo Clin Proc. 2008 May;83(5):529-35. doi: 10.4065/83.5.529.

PMID:
18452681
12.

HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn(2+) from nucleocapsid protein.

Morcock DR, Thomas JA, Sowder RC 2nd, Henderson LE, Crise BJ, Gorelick RJ.

Virology. 2008 May 25;375(1):148-58. doi: 10.1016/j.virol.2008.01.045. Epub 2008 Mar 4.

13.

Development of an illustrated medication schedule as a low-literacy patient education tool.

Kripalani S, Robertson R, Love-Ghaffari MH, Henderson LE, Praska J, Strawder A, Katz MG, Jacobson TA.

Patient Educ Couns. 2007 Jun;66(3):368-77. Epub 2007 Mar 6.

PMID:
17344015
14.

Predictors of medication self-management skill in a low-literacy population.

Kripalani S, Henderson LE, Chiu EY, Robertson R, Kolm P, Jacobson TA.

J Gen Intern Med. 2006 Aug;21(8):852-6.

15.

Use of handheld computers in medical education. A systematic review.

Kho A, Henderson LE, Dressler DD, Kripalani S.

J Gen Intern Med. 2006 May;21(5):531-7. Review.

16.

Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides.

Fisher RJ, Fivash MJ, Stephen AG, Hagan NA, Shenoy SR, Medaglia MV, Smith LR, Worthy KM, Simpson JT, Shoemaker R, McNitt KL, Johnson DG, Hixson CV, Gorelick RJ, Fabris D, Henderson LE, Rein A.

Nucleic Acids Res. 2006 Jan 24;34(2):472-84. Print 2006. Erratum in: Nucleic Acids Res. 2006;34(3):1082.

17.

Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

Morcock DR, Thomas JA, Gagliardi TD, Gorelick RJ, Roser JD, Chertova EN, Bess JW Jr, Ott DE, Sattentau QJ, Frank I, Pope M, Lifson JD, Henderson LE, Crise BJ.

J Virol. 2005 Feb;79(3):1533-42.

18.

Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.

Lifson JD, Rossio JL, Piatak M Jr, Bess J Jr, Chertova E, Schneider DK, Coalter VJ, Poore B, Kiser RF, Imming RJ, Scarzello AJ, Henderson LE, Alvord WG, Hirsch VM, Benveniste RE, Arthur LO.

AIDS Res Hum Retroviruses. 2004 Jul;20(7):772-87.

PMID:
15307924
19.

Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination.

Cheslock SR, Poon DT, Fu W, Rhodes TD, Henderson LE, Nagashima K, McGrath CF, Hu WS.

J Virol. 2003 Jun;77(12):7058-66.

20.

Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.

Gaddis NC, Chertova E, Sheehy AM, Henderson LE, Malim MH.

J Virol. 2003 May;77(10):5810-20.

21.

Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins.

Chertova E, Crise BJ, Morcock DR, Bess JW Jr, Henderson LE, Lifson JD.

Curr Mol Med. 2003 May;3(3):265-72. Review.

PMID:
12699362
22.

Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge.

Lifson JD, Piatak M Jr, Rossio JL, Bess J Jr, Chertova E, Schneider D, Kiser R, Coalter V, Poore B, Imming R, Desrosiers RC, Henderson LE, Arthur LO.

J Med Primatol. 2002 Aug;31(4-5):205-16.

PMID:
12390543
23.

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.

Chertova E, Bess JW Jr, Crise BJ, Sowder II RC, Schaden TM, Hilburn JM, Hoxie JA, Benveniste RE, Lifson JD, Henderson LE, Arthur LO.

J Virol. 2002 Jun;76(11):5315-25.

24.
25.

Chemical cleavage at aspartyl residues for protein identification.

Li A, Sowder RC, Henderson LE, Moore SP, Garfinkel DJ, Fisher RJ.

Anal Chem. 2001 Nov 15;73(22):5395-402.

PMID:
11816565
26.

Detection of Pasteurella multocida in pigs with porcine dermatitis and nephropathy syndrome.

Thomson JR, MacIntyre N, Henderson LE, Meikle CS.

Vet Rec. 2001 Oct 6;149(14):412-7.

PMID:
11678213
27.

Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.

Topol IA, McGrath C, Chertova E, Dasenbrock C, Lacourse WR, Eissenstat MA, Burt SK, Henderson LE, Casas-Finet JR.

Protein Sci. 2001 Jul;10(7):1434-45.

28.

Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.

Yovandich JL, Chertova EN, Kane BP, Gagliardi TD, Bess JW Jr, Sowder RC 2nd, Henderson LE, Gorelick RJ.

J Virol. 2001 Jan;75(1):115-24.

29.

Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.

Gorelick RJ, Benveniste RE, Lifson JD, Yovandich JL, Morton WR, Kuller L, Flynn BM, Fisher BA, Rossio JL, Piatak M Jr, Bess JW Jr, Henderson LE, Arthur LO.

J Virol. 2000 Dec;74(24):11935-49.

30.

Mucosal challenge of Macaca nemestrina with simian immunodeficiency virus (SIV) following SIV nucleocapsid mutant DNA vaccination.

Gorelick RJ, Lifson JD, Yovandich JL, Rossio JL, Piatak M Jr, Scarzello AJ, Knott WB, Bess JW Jr, Fisher BA, Flynn BM, Henderson LE, Arthur LO, Benveniste RE.

J Med Primatol. 2000 Aug;29(3-4):209-19.

PMID:
11085583
31.

Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer.

Guo J, Wu T, Anderson J, Kane BF, Johnson DG, Gorelick RJ, Henderson LE, Levin JG.

J Virol. 2000 Oct;74(19):8980-8.

32.

Nucleic acid binding properties of the simian immunodeficiency virus nucleocapsid protein NCp8.

Urbaneja MA, McGrath CF, Kane BP, Henderson LE, Casas-Finet JR.

J Biol Chem. 2000 Apr 7;275(14):10394-404.

33.

Actin-binding cellular proteins inside human immunodeficiency virus type 1.

Ott DE, Coren LV, Johnson DG, Kane BP, Sowder RC 2nd, Kim YD, Fisher RJ, Zhou XZ, Lu KP, Henderson LE.

Virology. 2000 Jan 5;266(1):42-51.

34.

Characterization of the block in replication of nucleocapsid protein zinc finger mutants from moloney murine leukemia virus.

Gorelick RJ, Fu W, Gagliardi TD, Bosche WJ, Rein A, Henderson LE, Arthur LO.

J Virol. 1999 Oct;73(10):8185-95.

36.
37.

Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function.

Urbaneja MA, Kane BP, Johnson DG, Gorelick RJ, Henderson LE, Casas-Finet JR.

J Mol Biol. 1999 Mar 19;287(1):59-75.

PMID:
10074407
38.

Probing the topography of HIV-1 nucleocapsid protein with the alkylating agent N-ethylmaleimide.

Chertova EN, Kane BP, McGrath C, Johnson DG, Sowder RC 2nd, Arthur LO, Henderson LE.

Biochemistry. 1998 Dec 22;37(51):17890-7.

PMID:
9922156
39.

Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.

Gorelick RJ, Benveniste RE, Gagliardi TD, Wiltrout TA, Busch LK, Bosche WJ, Coren LV, Lifson JD, Bradley PJ, Henderson LE, Arthur LO.

Virology. 1999 Jan 20;253(2):259-70.

40.

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.

Arthur LO, Bess JW Jr, Chertova EN, Rossio JL, Esser MT, Benveniste RE, Henderson LE, Lifson JD.

AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S311-9.

PMID:
9814959
41.

Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication.

Rein A, Henderson LE, Levin JG.

Trends Biochem Sci. 1998 Aug;23(8):297-301. Review.

PMID:
9757830
42.

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

Rossio JL, Esser MT, Suryanarayana K, Schneider DK, Bess JW Jr, Vasquez GM, Wiltrout TA, Chertova E, Grimes MK, Sattentau Q, Arthur LO, Henderson LE, Lifson JD.

J Virol. 1998 Oct;72(10):7992-8001.

43.
44.
45.

Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.

Ott DE, Coren LV, Copeland TD, Kane BP, Johnson DG, Sowder RC 2nd, Yoshinaka Y, Oroszlan S, Arthur LO, Henderson LE.

J Virol. 1998 Apr;72(4):2962-8.

46.

Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.

Fisher RJ, Rein A, Fivash M, Urbaneja MA, Casas-Finet JR, Medaglia M, Henderson LE.

J Virol. 1998 Mar;72(3):1902-9.

47.

Isolation of a novel Kunitz family protease inhibitor in association with Tethya hemolysin from the sponge Tethya ingalli.

O'Keefe BR, Beutler JA, Cardellina JH 2nd, Prather TR, Shoemaker RH, Sowder RC 2nd, Henderson LE, Pannell LK, Boyd MR.

J Nat Prod. 1997 Nov;60(11):1094-9.

PMID:
9392878
48.

Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells.

Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2200-8.

PMID:
9351390
49.

Binding of the nucleocapsid protein of type 1 human immunodeficiency virus to nucleic acids studied using phosphorescence and optically detected magnetic resonance.

Wu JQ, Ozarowski A, Maki AH, Urbaneja MA, Henderson LE, Casas-Finet JR.

Biochemistry. 1997 Oct 14;36(41):12506-18.

PMID:
9376355
50.

Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum.

Gustafson KR, Sowder RC 2nd, Henderson LE, Cardellina JH 2nd, McMahon JB, Rajamani U, Pannell LK, Boyd MR.

Biochem Biophys Res Commun. 1997 Sep 8;238(1):223-8.

PMID:
9299483

Supplemental Content

Loading ...
Support Center